Pro-inflammatory chitosan/poly(γ-glutamic acid) nanoparticles modulate human antigen-presenting cells phenotype and revert their pro-invasive capacity
| Autor: | Maria Gomez-Lazaro, Raquel Gonçalves, Maria José Oliveira, Graciosa Q. Teixeira, Susana G. Santos, Flávia Castro, Andreia M. Silva, Mário A. Barbosa, Catarina Leite Pereira, Marta Pinto |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Cell Survival T-Lymphocytes T cell Biomedical Engineering Antigen-Presenting Cells Biochemistry Biomaterials 03 medical and health sciences Immune system Antigen Cell Movement medicine Humans Neoplasm Invasiveness Particle Size Antigen-presenting cell Molecular Biology Cell Proliferation Inflammation Chitosan Tumor microenvironment Innate immune system CD40 biology Macrophages Cell Polarity Cell Differentiation Dendritic Cells General Medicine Endocytosis Interleukin-10 Phenotype 030104 developmental biology medicine.anatomical_structure Polyglutamic Acid Colonic Neoplasms Immunology Cancer cell biology.protein Cancer research Nanoparticles Biotechnology |
| Zdroj: | Acta Biomaterialia. 63:96-109 |
| ISSN: | 1742-7061 |
| Popis: | Anticancer immune responses depend on efficient presentation of tumor antigens and co-stimulatory signals provided by antigen-presenting cells (APCs). However, it is described that immature dendritic cells (DCs) and macrophages at the tumor site may have an immunosuppressive profile, which limits the activity of effector T cells and supports tumor progression. Therapeutic targeting of these innate immune cells, either aiming at their elimination or re-polarization towards an immunostimulatory profile, has been pointed as an attractive approach to control tumor progression. In the present work, we assessed the potential of Chitosan (Ch)/Poly(γ-glutamic acid) (γ-PGA) nanoparticles (NPs) to modulate macrophages and DCs inflammatory profile and to impair their ability to promote cancer cell invasion. Interestingly, Ch/γ-PGA NPs, prepared by co-acervation method, induced an immunostimulatory DCs phenotype, enhancing the expression of the co-stimulatory molecules CD86, CD40 and HLA-DR, and the secretion of the pro-inflammatory cytokines TNF-α, IL-12p40 and IL-6. Furthermore, Ch/γ-PGA NPs re-educated IL-10-stimulated macrophages towards a pro-inflammatory profile, decreasing the expression of CD163 and promoting the secretion of IL-12p40 and TNF-α. These alterations in the immune cells phenotype promoted CD4 + and CD8 + T cell activation/proliferation and partially inhibited APCs’ ability to induce colorectal cancer cell invasion. Overall, our findings open new perspectives on the use of Ch/γ-PGA NPs as an immunomodulatory therapy for antigen-presenting cells reprogramming, providing a new tool for anticancer therapies. Statement of Significance The immune system is responsible to detect and destroy abnormal cells preventing the development of cancer. However, the immunosuppressive tumor microenvironment can compromise the immune response favoring tumor progression. Thus, immune system modulation towards an immunostimulatory profile can improve anticancer therapies. This research focus on the development of chitosan/poly(γ-glutamic acid) nanoparticles (NPs) to modulate human antigen-presenting cells (APCs) phenotype and to counteract their pro-invasive capacity. Interestingly, Ch/γ-PGA NPs had a prominent effect in inducing macrophages and dendritic cells immunostimulatory phenotype, thus favoring T cell proliferation and inhibiting colorectal cancer cell invasion. We propose that their combination with other immunomodulatory drugs or conventional anticancer therapies can improve patients’ outcome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect